GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr

GlaxoSmithKline Pharmaceuticals on Monday posted 29 per cent increase in consolidated profit after tax at Rs 296 crore for ...

GlaxoSmithKline Consolidated December 2025 Net Sales at Rs 1,041.26 crore, up 9.67% Y-o-Y

Reported Consolidated quarterly numbers for GlaxoSmithKline Pharmaceuticals are: Net Sales at Rs 1,041.26 crore in December ...
Devdiscourse

GlaxoSmithKline's Profit Surge: Navigating Challenges with Strategic Resilience

GlaxoSmithKline Pharmaceuticals achieved a 29% increase in its consolidated profit during the third quarter of 2025, reaching Rs 296 crore. Revenue also rose to Rs 1,041 crore. The company's success ...

GlaxoSmithKline Standalone December 2025 Net Sales at Rs 1,022.59 crore, up 8.06% Y-o-Y

Reported Standalone quarterly numbers for GlaxoSmithKline Pharmaceuticals are: Net Sales at Rs 1,022.59 crore in December ...
CNBCTV18

GlaxoSmithKline Q3 net profit surges 29% on higher revenue and EBITDA

Net profit ₹295.6 crore up 28.6% YoY, revenue ₹1,041 crore up 9.7% YoY, EBITDA ₹371.1 crore up 27.2% with operating margin at 35.6%; nine-month net profit at ₹758.12 crore, total income ₹2,935.78 ...

GlaxoSmithKline (GSK) Receives a Hold from UBS

In addition to UBS, GlaxoSmithKline also received a Hold from Bank of America Securities’s Sachin Jain in a report issued yesterday. However, today, Barclays maintained a Sell rating on ...